Anaphylaxis triggered by iodinated contrast media was rare, but severe and refractory cases indicated the need for ...
BioArctic AB's (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) for Leqembi Iqlik subcutaneous ...
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.
Intel Corporation stock outlook after a 17% pullback: mixed 1Q FY2026 guidance, solid data center demand, 18A/14A progress, ...
The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results